title: Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver.
abstract: Hepatic encephalopathy (HE) is a major complication that develops in some form and at some stage in a majority of patients with liver cirrhosis. Overt HE occurs in approximately 30-45% of cirrhotic patients. Minimal HE (MHE), the mildest form of HE, is characterized by subtle motor and cognitive deficits and impairs health-related quality of life. The Indian National Association for Study of the Liver (INASL) set up a Working Party on MHE in 2008 with a mandate to develop consensus guidelines on various aspects of MHE relevant to clinical practice. Questions related to the definition of MHE, its prevalence, diagnosis, clinical characteristics, pathogenesis, natural history and treatment were addressed by the members of the Working Party.
authors.affiliation: Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India. rkpsdhiman@hotmail.com
authors.forename: Radha K
authors.initials: RK
authors.lastname: Dhiman
authors.forename: Vivek A
authors.initials: VA
authors.lastname: Saraswat
authors.forename: Barjesh K
authors.initials: BK
authors.lastname: Sharma
authors.forename: Shiv K
authors.initials: SK
authors.lastname: Sarin
authors.forename: Yogesh K
authors.initials: YK
authors.lastname: Chawla
authors.forename: Roger
authors.initials: R
authors.lastname: Butterworth
authors.forename: Ajay
authors.initials: A
authors.lastname: Duseja
authors.forename: Rakesh
authors.initials: R
authors.lastname: Aggarwal
authors.forename: Deepak
authors.initials: D
authors.lastname: Amarapurkar
authors.forename: Praveen
authors.initials: P
authors.lastname: Sharma
authors.forename: Kaushal
authors.initials: K
authors.lastname: Madan
authors.forename: Samir
authors.initials: S
authors.lastname: Shah
authors.forename: Avnish K
authors.initials: AK
authors.lastname: Seth
authors.forename: Rakesh K
authors.initials: RK
authors.lastname: Gupta
authors.forename: Abraham
authors.initials: A
authors.lastname: Koshy
authors.forename: Ramesh R
authors.initials: RR
authors.lastname: Rai
authors.forename: Jang B
authors.initials: JB
authors.lastname: Dilawari
authors.forename: Sri Prakash
authors.initials: SP
authors.lastname: Mishra
authors.forename: Subrat K
authors.initials: SK
authors.lastname: Acharya
mesh_terms: D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003245:Consensus Statements as Topic; D018450:Disease Progression; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D017410:Practice Guidelines as Topic; D015995:Prevalence; D019936:Probiotics / Q000627:therapeutic use*; D011788:Quality of Life; D012955:Societies, Medical; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D005765:Gastrointestinal Agents